Goldman Sachs Upgrades Genmab A/S (GEN:DC) (GMAB) to Buy

April 22, 2026 12:56 AM

Goldman Sachs analyst Rajan Sharma upgraded Genmab A/S (GEN:DC) (NASDAQ: GMAB) from Neutral to Buy with a price target of ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found